Sana Biotechnology (SANA) Assets Average (2021 - 2026)

Sana Biotechnology has reported Assets Average for 6 years, with the latest figure at $395.2 million in Q1 2026.

• Quarterly Assets Average fell 16.48% year-over-year to $395.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $395.2 million (down 16.48% YoY) and the FY2025 annual result came in at $459.0 million, down 13.92% from the prior year.
• Assets Average eased to $395.2 million in Q1 2026 per SANA's latest filing, from $426.2 million in the prior quarter.
• Over five years, Assets Average peaked at $1.1 billion in Q1 2022 and troughed at $395.2 million in Q1 2026.
• A 5-year average of $656.6 million and a median of $623.3 million in 2024 frame the typical range for Assets Average.
• The sharpest annual moves came in 2022 and 2025: Assets Average increased 6.99% in 2022, then slumped 37.92% in 2025.
• Over 5 years, Assets Average stood at $860.4 million in 2022, then slumped by 30.46% to $598.4 million in 2023, then slipped by 11.39% to $530.2 million in 2024, then fell by 19.62% to $426.2 million in 2025, then retreated by 7.26% to $395.2 million in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $395.2 million, $426.2 million, and $398.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.